Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating immune-related intestinal diseases in adults

Official title: Pathogenic Study of Adult Immune Enteropathies

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT04280510 · Data updated 2026-11-12

This study looks at how certain immune-related gut diseases in adults affect the balance of cells in the intestines and liver to see if it can lead to serious complications.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations4 sites (Créteil and 3 other locations)
StatusRecruiting
StartedFebruary 27, 2020
Main results expectedFebruary 27, 2030
Study endsFebruary 27, 2033
Registry record updatedOctober 27, 2026
Trial IDNCT04280510 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and over who are diagnosed with celiac disease, autoimmune enteropathy, or inflammatory bowel diseases.

Probably not a fit

Patients who are pregnant or unable to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines the mechanisms that disrupt intestinal homeostasis in conditions such as celiac disease, autoimmune enteropathy, and inflammatory bowel diseases. It aims to understand how lymphocyte transformations can lead to lymphomatous complications associated with these immune enteropathies. Additionally, the study will assess the loss of hepatic lymphocytic homeostasis in liver-related autoimmune diseases through blood sample collection and gastrointestinal biopsies.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of immune enteropathies, potentially reducing complications for patients.

How similar studies have gone: While this study focuses on specific mechanisms in immune enteropathies, similar studies have shown promise in understanding autoimmune diseases, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or over
* affiliated to social insurance
* signed informed consent

Exclusion Criteria:

* pregnancy
* under guardianship
* not able to sign informed consent

Where it's running

  • Hôpital Cochin
    Paris, France
    Recruiting
  • Hôpital Henri Mondor
    Créteil, France
    Not yet recruiting
  • Hôpital Bicêtre
    Le Kremlin-Bicêtre, France
    Not yet recruiting
  • Hôpital Saint Louis
    Paris, France
    Not yet recruiting

Study contacts

  • Principal investigator: Georgia MALAMUT, MD, PhD — APHP, Université de Paris (Université Paris Descartes)
  • Study coordinator: Georgia MALAMUT, MD, PhD
  • Email: georgia.malamut@aphp.fr
  • Phone: 33 1 58 41 41 76

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.